Table 3.

Effect of d-Nav on Patient HbA1c Levels at 90-days (n=192)

Patient Cohort	Average HbA1c at Enrollment	Average HbA1c after 3 months of d-Nav	Percentage Point Difference (a)
All patients (n=192; 100.00%)	9.37%	7.71%	−1.66 (p<0.001)**
Target Group (n=54; 28.13%)	9.30%	7.86%	−1.44 (p<0.001)**
HbA1c > 9% at baseline (n=98; 51.04%)
HbA1c ≤ 9% (n=84; 85.71%)	10.49%	7.63%	−2.86 (p<0.001)**
HbA1c > 9% (n=14; 14.29%)	11.05%	10.20%	−0.85 (p=0.04)*

Notes: Percentage point difference between baseline and 3-month assessment. See text.

^*Significant at the 95% level

^**Significant at the 99% level